The TCV Vaccine Market represents a critical segment of the global immunization landscape, focusing on the prevention of typhoid fever caused by the bacterium Salmonella Typhi. Unlike traditional Vi polysaccharide vaccines, TCVs are conjugated to a protein carrier, which triggers a more robust and long-lasting immune response, even in infants as young as six months. This technological...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek